The adverse effects of a wide range of chemical therapeutic agents are manifested in the skin. In fact, the term 'drug reaction' is almost synonymous in the minds of most physicians with the development of an 'allergic rash'. However, most chemical substances that elicit such a reaction are of too low molecular weight to be able to induce an immune response in isolation and have been considered, since the time of Ehrlich, to act as immunogens by combination in vivo with higher molecular weight protein molecules. Landsteiner and Jacobs (1935) showed that they could immunize animals with chloro-and nitrosubstitute benzenes only if these were attached covalently to proteins.
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Fixed Drug Eruptions
One of the more common manifestations of drug allergy in the skin is the so-called 'fixed drug eruption'. This localized eruption always occurs at the same time and the same site after systemic absorption of the sensitizing agent. Among the drugs that are well known to produce this type of reaction are barbiturates, sulphonamides, phenolphthalein and phenazone. There is little concrete evidence available as to why the eruption always occurs at one particular site. However, during experiments on contact sensitization with potassium dichromatc (K2Cr2O7) it was found that if an animal was given the chemical intravenously, the site of the reaction would be that of previous induced contact (Polak and Turk, 1968 
